Skip to main content
HR 2118 107th Congress House Health Armed Forces and National Security Congress Congressional reporting requirements Department of Health and Human Services Disability insurance Disabled Economics and Public Finance Education Federal advisory bodies Federal aid to medical research Government Operations and Politics Government publicity Health education Health insurance Health surveys Law Licenses Lyme disease Medical ethics

Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act

Introduced: June 8, 2001 See on congress.gov
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 18, 2001
Referred to the Subcommittee on Health.
Jun 8, 2001
Referred to the House Committee on Energy and Commerce.
Jun 8, 2001
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Lyme and Infectious Disease Information and Fairness in Treatment (LIFT) Act - Establishes the Tick-Borne Disorders Advisory Committee in the Office of the Secretary of Health and Human Services (HHS). Directs the Committee to advise the Secretary and the Assistant Secretary of HHS and the Social Security Administration (SSA) Commissioner regarding how to: (1) provide public input on the public's needs regarding tick-borne disorders (lyme and other infectious diseases) so that government agencies can coordinate and more effectively plan and execute their activities; and (2) develop informed responses to constituency groups regarding the efforts and progress of the HHS and SAA.

Authorizes appropriations to the Centers for Disease Control and Prevention to: (1) focus on developing better diagnostic tools and tests, expanding educational efforts, and re-educating clinicians, medical license boards, and health care insurers about the inappropriate uses of the Lyme disease case surveillance definition in patient diagnosis and treatment; and (2) collaborate with the National Institutes of Health, the Department of Defense, and other appropriate agencies for further research on tick-borne disorders, including study of preventive methods to decrease exposure to them.

Requires the Director of the National Institutes of Health to coordinate activities and research regarding tick-borne diseases across Institutes to encourage collaborative research.

What's happening now June 18, 2001

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act. 107th Congress. Open America. https://openamerica.io/bill/107-HR-2118/
MLA
"H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-2118/.
Bluebook (legal)
H.R. 2118, 107th Cong. (2026), https://openamerica.io/bill/107-HR-2118/.
Markdown link
[H.R. 2118: Lyme and Infectious Disease Information and Fairness in Treatment (LIIFT) Act](https://openamerica.io/bill/107-HR-2118/)
Report a problem